This bill adds a new section to chapter 74.09 RCW and directs the Health Care Authority (HCA), working with the Department of Health, the Robert Bree collaborative, and Medicaid managed care organizations (MCOs), to develop by December 31, 2025 education and outreach materials for Medicaid clients addressing four performance measures: breast cancer screening, cervical cancer screening, timeliness of prenatal care, and postpartum care. By the same date HCA must also develop an implementation plan to incentivize MCOs and to improve fee‑for‑service performance on those measures, develop billing guide instructions for fee‑for‑service providers, and amend MCO contracts to encourage use of CPT code 0500F for earlier identification of pregnant women; HCA may include incentives for use of that code. HCA and MCOs must seek collaboration from the American Cancer Society and the American College of Obstetricians and Gynecologists, and performance is to be measured by an external quality improvement organization defined by reference to 42 C.F.R. §438.354 as it existed on the section’s effective date. The bill imposes new procedural and programmatic requirements rather than creating new crimes or changing criminal penalties: it requires development of materials, contractual changes, an incentive implementation plan, and recurring reporting. HCA must submit a report to the governor and specified legislative committees by November 30, 2028, and annually thereafter, detailing savings from improvements (for each prior plan year up to the previous three plan years) and specified data items including implementation plan distinctions between fee‑for‑service and managed care, work to incentivize MCOs and improve fee‑for‑service, stated offsets, enrollment and eligibility counts, counts and percentages receiving each screening or care, timeliness of prenatal care, and three‑year comparisons for each performance measure. The extracted text does not specify the new section’s effective date, the exact benchmarks or definitions for “timeliness of prenatal care” or eligibility for the listed services, what is meant by the required “offsets,” funding or enforcement mechanisms, or which legislative committees are the required report recipients.

If enacted, the Health Care Authority will need to create outreach materials, a plan to incentivize better performance, billing guidance, and contract changes with managed care organizations by December 31, 2025, all aimed at increasing breast and cervical cancer screenings and improving prenatal and postpartum care for Medicaid clients. Managed care organizations and fee-for-service providers will be asked to collaborate and to encourage earlier pregnancy identification using CPT code 0500F, and HCA must begin reporting estimated savings and a set of performance counts and comparisons to the governor and legislative committees annually starting November 30, 2028. The most affected parties are HCA (which gains new planning, contract, and reporting duties), MCOs (which must collaborate and face new incentives or contract expectations to raise measured performance), and fee-for-service providers (who will receive billing instructions and may be asked to use CPT 0500F). Medicaid clients are likely to receive more targeted outreach and earlier pregnancy identification. Important details are missing from the text provided — the effective date, how incentives will be designed or funded, specific performance benchmarks or definitions of “timeliness,” and what “offsets” mean — so the actual costs, funding shifts, and how much outcomes will change remain unclear.